Confluent cultures of human fetal lung fibroblasts degrade approximately 10% of their newly synthesized collagen within the cell prior to secretion. This basal level of intracellular degradation could not be inhibited by colchicine or cytochalasin B, inhibitors of microtubular and microfilament function, respectively, or by N -tosyl-L-lysine chloromethyl ketone, chloroquine, or NH4C1, inhibitors of Iysosomal enzymes.In contrast, cells in early logarithmic growth degrade approximately 30% of their newly synthesized collagen. This enhanced degradation of collagen in rapidly growing cells could be suppressed by inhibitors of lysosomal proteases and partially inhibited by disrupters of microtubular and microfilament function. A significant prootion of the collagen synthesized by these cultures contained prolyl residues that were incompletely hydroxylated. Because such collagen is "defective" (i.e., not capable of assuming a triple helical conformation), the results suggest that enhanced intracellular degradation may be a mechanism by which cells control the quality of collagen they produce. To test this hypothesis, confluent cells were incubated with the proline analog cis4hydroxyproline; such cells demonstrated en anced collagen degradation that could be inhibited by agents that interfere with lysosomal, microtubular, or microfilament function. Because collagen containing cis4 hydroxyproline cannot form a perfect triple helix, the data are consistent with the concept that defective collagen is recognized by cells and degraded prior to secretion. Thus, the proportion of newly synthesized collagen that undergoes intracellular degradation seems to be modulated, in part, by the conformation of the collagen molecule. Intracellular proteolysis may represent a means by which collagen-producing cells regulate the quality and quantity of collagen available for extracellular function. Although the exact mechanism of intracellular collagen degradation is unknown, the data presented here are consistent with a role for lysosomal proteases in this process. The normal collagen molecule is a triple helical, rod-like structure. Inherent in this structure is the property to polymerize into extracellular fibers that play a major role in defining organ structure and function (1-4). The ability of collagen to form fibers is dependent on its triple helical conformation. To form this helix, each collagen polypeptide chain must have a specific primary sequence, the most important aspect of which is a repetitive Gly-X-Y triplet; approximately 30% of the X residues are proline and 30% of the Y residues are trans-4-hydroxyproline (1)(2)(3)(4)(5). Several studies have demonstrated that, if a sufficient number of Y position residues are not filled with hydroxyproline, the resulting collagen molecule is "defective"-i.e., it cannot form a perfect triple helical structure at body temperature (5). Such defective collagen molecules will not polymerize into normal collagen fibers and thus cannot serve their function in the extracellular mat...